Latest news with #analystestimates
Yahoo
a day ago
- Business
- Yahoo
MP Materials Second Quarter 2025 Earnings: Beats Expectations
MP Materials (NYSE:MP) Second Quarter 2025 Results Key Financial Results Revenue: US$57.4m (up 84% from 2Q 2024). Net loss: US$30.9m (loss narrowed by 9.3% from 2Q 2024). US$0.19 loss per share (improved from US$0.21 loss in 2Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period MP Materials Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 26%. Earnings per share (EPS) also surpassed analyst estimates by 15%. Looking ahead, revenue is forecast to grow 34% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Metals and Mining industry in the US. Performance of the American Metals and Mining industry. The company's shares are up 17% from a week ago. Risk Analysis Before you take the next step you should know about the 1 warning sign for MP Materials that we have uncovered. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
2 days ago
- Business
- Yahoo
TeraWulf Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
Explore TeraWulf's Fair Values from the Community and select yours TeraWulf (NASDAQ:WULF) Second Quarter 2025 Results Key Financial Results Revenue: US$47.6m (up 34% from 2Q 2024). Net loss: US$18.4m (loss widened by 65% from 2Q 2024). US$0.047 loss per share (further deteriorated from US$0.033 loss in 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period TeraWulf EPS Beats Expectations, Revenues Fall Short Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) exceeded analyst estimates by 18%. Looking ahead, revenue is forecast to grow 41% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Software industry in the US. Performance of the American Software industry. The company's shares are up 5.7% from a week ago. Risk Analysis Before we wrap up, we've discovered 3 warning signs for TeraWulf (1 shouldn't be ignored!) that you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
2 days ago
- Business
- Yahoo
Canadian Natural Resources Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
Canadian Natural Resources (TSE:CNQ) Second Quarter 2025 Results Key Financial Results Revenue: CA$8.70b (down 3.9% from 2Q 2024). Net income: CA$2.46b (up 43% from 2Q 2024). Profit margin: 28% (up from 19% in 2Q 2024). The increase in margin was driven by lower expenses. EPS: CA$1.18 (up from CA$0.80 in 2Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period Canadian Natural Resources EPS Beats Expectations, Revenues Fall Short Revenue missed analyst estimates by 1.5%. Earnings per share (EPS) exceeded analyst estimates by 81%. Looking ahead, revenue is forecast to stay flat during the next 3 years compared to a 2.6% growth forecast for the Oil and Gas industry in Canada. Performance of the Canadian Oil and Gas industry. The company's shares are down 2.4% from a week ago. Risk Analysis Before we wrap up, we've discovered 1 warning sign for Canadian Natural Resources that you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
2 days ago
- Business
- Yahoo
Sutro Biopharma Second Quarter 2025 Earnings: Beats Expectations
Sutro Biopharma (NASDAQ:STRO) Second Quarter 2025 Results Key Financial Results Revenue: US$63.7m (up 148% from 2Q 2024). Net loss: US$11.5m (loss narrowed by 76% from 2Q 2024). US$0.14 loss per share (improved from US$0.59 loss in 2Q 2024). This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period Sutro Biopharma Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates significantly. Earnings per share (EPS) also surpassed analyst estimates by 63%. Looking ahead, revenue is expected to decline by 18% p.a. on average during the next 3 years, while revenues in the Biotechs industry in the US are expected to grow by 19%. Performance of the American Biotechs industry. The company's share price is broadly unchanged from a week ago. Risk Analysis It's necessary to consider the ever-present spectre of investment risk. We've identified 5 warning signs with Sutro Biopharma (at least 1 which is significant), and understanding them should be part of your investment process. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 days ago
- Business
- Yahoo
BlackSky Technology Second Quarter 2025 Earnings: EPS Misses Expectations
BlackSky Technology (NYSE:BKSY) Second Quarter 2025 Results Key Financial Results Revenue: US$22.2m (down 11% from 2Q 2024). Net loss: US$41.2m (loss widened by 339% from 2Q 2024). US$1.27 loss per share (further deteriorated from US$0.52 loss in 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period BlackSky Technology EPS Misses Expectations Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 183%. Looking ahead, revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the Professional Services industry in the US. Performance of the American Professional Services industry. The company's shares are down 9.4% from a week ago. Risk Analysis What about risks? Every company has them, and we've spotted 3 warning signs for BlackSky Technology (of which 1 doesn't sit too well with us!) you should know about. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
